Biggest News Aggregation in the World
๐Ÿ“ฐ Multiple News

Page 361 - Multiple News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Multiple. Real-time updates on events, politics, business and more.

Bristol Myers Squibb Presents New Data Showing Effect of Early Zeposia (ozanimod) Treatment in Improving and Preserving Cognitive Function in People With Relapsing Multiple Sclerosis

Results showed improved or preserved cognitive function in a majority of people regardless of baseline values, with the greatest effect observed in almost 80% of people with high thalamic volume (45.5%
Jonathan Sadeh Bristol Myers Squibb John Deluca Kessler Foundation European Academy Of Neurology European Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Oncopeptides AB: CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma

STOCKHOLM, June 23, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological
United Kingdom Oncopeptides Pepaxti Annika Muskantor Rolf Gulliksen Klaas Bakker Pieter Sonneveld

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science